Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Audit Finding: SOP Absence

GMP Compliance Risks When SOPs Are Missing for Critical Activities

Posted on By

GMP Compliance Risks When SOPs Are Missing for Critical Activities Addressing the Lack of SOPs for Critical GMP Operations Introduction to the Audit Finding 1. Why SOP Absence is a GMP Concern The absence of Standard Operating Procedures (SOPs) for critical GMP operations is one of the most serious findings in pharmaceutical audits. SOPs provide…

Read More “GMP Compliance Risks When SOPs Are Missing for Critical Activities” »

GMP Audit Findings, SOP Absence

Regulatory Impact of Missing SOPs for Deviation Management

Posted on By

Regulatory Impact of Missing SOPs for Deviation Management Ensuring Deviation Control with Documented SOPs in GMP Systems Introduction to the Audit Finding 1. Overview of the Compliance Gap Deviation management is a critical GMP requirement. When a site lacks a formal SOP to govern the handling, classification, investigation, and closure of deviations, it creates a…

Read More “Regulatory Impact of Missing SOPs for Deviation Management” »

GMP Audit Findings, SOP Absence

Compliance Risks from Missing SOPs for Vendor Qualification

Posted on By

Compliance Risks from Missing SOPs for Vendor Qualification GMP Consequences of Not Documenting Vendor Qualification Procedures Introduction to the Audit Finding 1. Criticality of Vendor Qualification Vendor qualification is a foundational requirement in the pharmaceutical supply chain. It ensures that materials, components, and services meet predefined GMP and quality criteria. 2. Absence of a Written…

Read More “Compliance Risks from Missing SOPs for Vendor Qualification” »

GMP Audit Findings, SOP Absence

GMP Audit Risk: Absence of SOPs for Data Integrity Practices

Posted on By

GMP Audit Risk: Absence of SOPs for Data Integrity Practices Why Absence of SOPs for Data Integrity Threatens GMP Compliance Introduction to the Audit Finding 1. The Core Issue The complete absence of SOPs that define data integrity expectations, monitoring, and controls is a significant GMP gap. 2. Implications This exposes the site to risks…

Read More “GMP Audit Risk: Absence of SOPs for Data Integrity Practices” »

GMP Audit Findings, SOP Absence

Absence of SOP for Self-Inspections and Internal Audits: A Critical GMP Gap

Posted on By

Absence of SOP for Self-Inspections and Internal Audits: A Critical GMP Gap Why Lack of SOP for Self-Inspections and Internal Audits Signals Compliance Failure Introduction to the Audit Finding 1. Missing Foundation Self-inspections are a GMP-mandated practice. Absence of an SOP formalizing them means the program is non-existent or inconsistent. 2. Undermined QA Oversight Without…

Read More “Absence of SOP for Self-Inspections and Internal Audits: A Critical GMP Gap” »

GMP Audit Findings, SOP Absence

How to Create an SOP for Temperature Excursions During Pharma Transport

Posted on By

How to Create an SOP for Temperature Excursions During Pharma Transport Developing SOPs for Managing Temperature Excursions in Pharma Logistics Introduction to the Audit Finding 1. Summary of the Issue Several GMP audits reveal that pharmaceutical companies lack documented SOPs to handle temperature excursions occurring during transport of drugs. 2. Why It Matters Failure to…

Read More “How to Create an SOP for Temperature Excursions During Pharma Transport” »

GMP Audit Findings, SOP Absence

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme